news, page-5

great newsletter. so much going on.

quote:

a number of institutions have made
signifi cant progress with the development
of liposomal and injectable
dosage formats for Bioeffective® R.
Once registration is granted in the
next few weeks, our focus will switch
to production and the important step
The last few months has seen our
research and development team
in St Petersburg focussed almost entirely
on responding to data requests
from the Ministry of Health as part of
the Ropren approval process.
At the same time, colleagues in
of technological integration with
SibEX. By August or September,
we expect to be in an unassailable
leadership position in relation to the
science and the production of plant
polyprenols.